Moreover, within patients with EGFR-amplified glioma, patients harbored EGFR-mutant showed worse prognosis, compared to EGFR-wt patients, implying EGFR mutations and amplifications might have superimposed impacts on downstream biological processes. The gene discussed is EGFR; the disease is glioma.